- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03324256
Energy Drinks and Vascular Function
May 16, 2019 updated by: University of Florida
Acute Effect of Energy Drinks on Vascular Function
The purpose of this study will be to examine the acute effect of commercially available energy products on endothelial function, arterial stiffness and thrombosis in healthy young males.
Study Overview
Status
Completed
Conditions
Detailed Description
The use of energy products has significantly increased in the last few years and is especially high among young men.
The present study will compare the acute effect of a commercially available energy drink, energy gum, coffee and control beverage on endothelial function, arterial stiffness and circulating markers of thrombosis, inflammation and oxidative stress.
Study Type
Interventional
Enrollment (Actual)
19
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32611
- University of Florida
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 28 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Being Male
- 18-30 years of age
- No indication of major clinical disease (e.g. diabetes, hypertension, significant arrhythmias, syncope and cardiovascular disease)
- BMI ≤ 30 kg/m^2 and blood pressure ≤ 140/90 mmHg
- Consumption of <400mg of caffeine/day
- Prior history of consumption of energy drinks
Exclusion criteria:
- Being female
- Age <18 or >30 years
- BMI> 30 kg/m^2 and blood pressure > 140/90 mmHg
- Use of medication that may affect vascular measures
- Use of tobacco products including smoking
- Vegan or vegetarian diet
- Being energy drink or caffeine naïve or consumption of >400 mg of caffeine/day
- Consumption of >1 energy drinks per month
- Being a shift worker
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Energy drink and placebo gum
Commercially-available energy drink (16oz) + 2 pieces of placebo gum
|
16 oz cold commercially-available energy drink
2 pieces of commercially-available placebo gum
|
Active Comparator: Caffeinated drink and placebo gum
Commercially-available caffeinated drink (16oz) + 2 pieces of placebo gum
|
2 pieces of commercially-available placebo gum
16oz cold commercially-available caffeinated drink
|
Active Comparator: Control drink and energy gum
Control drink (16oz) + 2 pieces of energy gum
|
2 pieces of commercially-available energy gum
16oz cold control drink
|
Placebo Comparator: Control drink and placebo gum
Control drink (16oz) + 2 pieces of placebo gum
|
2 pieces of commercially-available placebo gum
16oz cold control drink
|
Active Comparator: Energy drink and total sleep deprivation
Commercially-available energy drink (16oz) + 2 pieces of placebo gum following total sleep deprivation
|
16 oz cold commercially-available energy drink
2 pieces of commercially-available placebo gum
24-hour total sleep deprivation prior to consumption of energy drink and placebo gum
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in endothelial function
Time Frame: Before and 1 and 2 hrs following consumption of drink and gum
|
Brachial artery flow-mediated dilation
|
Before and 1 and 2 hrs following consumption of drink and gum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in arterial stiffness
Time Frame: Before and 1 and 2 hrs following consumption of drink and gum
|
Carotid to femoral pulse wave velocity
|
Before and 1 and 2 hrs following consumption of drink and gum
|
Change in wave reflection
Time Frame: Before and 1 and 2 hrs following consumption of drink and gum
|
Augmentation index
|
Before and 1 and 2 hrs following consumption of drink and gum
|
Change in peripheral and central blood pressures
Time Frame: Before and 1 and 2 hrs following consumption of drink and gum
|
Brachial and aortic blood pressures
|
Before and 1 and 2 hrs following consumption of drink and gum
|
Change in thrombosis and platelet function
Time Frame: Before and 1 and 2 hrs following consumption of drink and gum
|
Thromboelastograph and platelet aggregation tests
|
Before and 1 and 2 hrs following consumption of drink and gum
|
Change in circulating factors related to vascular function
Time Frame: Before and 1 and 2 hrs following consumption of drink and gum
|
Circulating levels of Trimethylamine N-oxide (TMAO) and markers of oxidative stress and inflammation
|
Before and 1 and 2 hrs following consumption of drink and gum
|
Change in heart rhythm
Time Frame: Before and 1 and 2 hrs following consumption of drink and gum
|
Electrocardiogram
|
Before and 1 and 2 hrs following consumption of drink and gum
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 12, 2018
Primary Completion (Actual)
May 16, 2019
Study Completion (Actual)
May 16, 2019
Study Registration Dates
First Submitted
October 20, 2017
First Submitted That Met QC Criteria
October 24, 2017
First Posted (Actual)
October 27, 2017
Study Record Updates
Last Update Posted (Actual)
May 20, 2019
Last Update Submitted That Met QC Criteria
May 16, 2019
Last Verified
May 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB201700678
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vascular Function
-
University of California, DavisCompletedVascular Function; Platelet AggregationUnited States
-
Maastricht University Medical CenterCompleted
-
Wageningen UniversityTop Institute Food and NutritionCompletedHypertension | Blood Pressure | Vascular Function | Renal FunctionNetherlands
-
Institut National de la Santé Et de la Recherche...UnknownFrench PNNS Guidelines in Vascular Function
-
Unilever R&DRadboud University Medical CenterCompletedVascular Function
-
University of EdinburghUmeå University; NHS LothianCompleted
-
Unilever R&DSprim Advanced Life SciencesCompleted
-
Maastricht University Medical CenterActive, not recruiting
-
University of Mississippi Medical CenterTerminatedVascular Function | Racial DisparityUnited States
-
Maastricht University Medical CenterAlpro FoundationCompletedCerebral Blood Flow | Cognitive Performance | Glucose Metabolism | Brain Vascular FunctionNetherlands
Clinical Trials on energy drink
-
University of the PacificCompletedCardiovascular DiseasesUnited States
-
Mayo ClinicCompletedCardiovascular System | Hemodynamics | Energy DrinksUnited States
-
University of the PacificCompletedBlood Pressure | Electrical Alternation of HeartUnited States
-
Université de MontréalUnknown
-
Karolinska InstitutetRegion Stockholm; Research department, Ersta HospitalTerminated
-
University of the PacificCompletedCardiovascular DiseasesUnited States
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
David Grant U.S. Air Force Medical CenterCompletedQTc IntervalUnited States
-
Utrecht Institute for Pharmaceutical SciencesRed Bull GmbHCompleted